Ryan McBride

Articles by Ryan McBride

UPDATED: Quintiles adds in-house genomic testing with latest buyout

Quintiles has scooped up a provider of genomic testing and analysis as the global pharma services company beefs up its internal capabilities to support the development of personalized drugs. With the buyout of Expression Analysis, Quintiles builds on a series of acquisitions and alliances that advance the genomics revolution into research labs and clinical trials.

Report sheds light on pharma and CRO trial enrollment woes

A DecisionView study shows that only 6% of drug trials wrap up on time, with 72% of studies missing deadlines by more than a month.

CRO lobby steps up social media outreach on YouTube

Clinical research organizations have grown their share of global clinical research business over the years, and the contract drug developers have found an online platform to carry their message around the world: YouTube.

Big quarterly loss whacks ex-Biogen chief's CMO amid transition

Wait until the second half of the fiscal year was Patheon ($PTI) CEO Jim Mullen's message after the contract drugmaker reported a $20.9 million loss.

Devicemakers eye outsourcing to limit hit from Obama tax

The medical device industry has waged war on a new tax on device makers as part of Obama's healthcare reform, and companies have begun talking up plans to outsource manufacturing work overseas as a result of the tax.

Biosimilars growth draws contract labs into the fray

With the market for biosimilars expected to spiral, drug research providers Celerion and Ricerca Biosciences have allied to extend their services to customers developing copycat versions of...

Aptiv nails down software deal to fuel adaptive trials services

Aptiv Solutions has grabbed a key piece to the tech puzzle it has been assembling to provide drug and device developers with adaptive clinical trials. The Reston, VA-based CRO, which launched last...

New CRO grows from ashes of cuts at Pfizer

Ex-Pfizer researcher Andrew McElroy has made the quick transition into becoming his own boss at a new contract services group after his job at the drug giant's Sandwich, U.K., site was axed last...

Quintiles $300M loan plan yields info on big year for outsourcing

Quintiles Transnational aims to borrow $300 million in a secured term loan to help fund a $335 million dividend for shareholders, after the company posted double-digit revenue growth last year,...

FDA cracks down on Chinese heparin material providers

The contaminated heparin saga continues. The FDA has put 14 more Chinese suppliers that made a tainted ingredient for creating the widely used blood thinner on a watch list, and U.S. regulators are...